Capstone Therapeutics Corp/ US14068E2081 /
| 2024-05-10 5:28:02 PM | Chg. -0.3750 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 4.6250USD | -7.50% | 400 Turnover: 1,825 |
-Bid Size: - | -Ask Size: - | 4.6250 | 4.5000 |
GlobeNewswire
2018-05-07
LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China
GlobeNewswire
2017-07-17
Capstone Therapeutics Announces Transaction for Sale of Shares of Its Common Stock and Secured Loan
GlobeNewswire
2016-12-19
Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study
